Close Up Logo HD Blue.jpg
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
February 01, 2022 14:00 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Feb. 01, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for BLI, PSFE, RVNC, RAAS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
January 25, 2022 13:00 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 24, 2022 11:15 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 24, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Revance Therapeutics, Inc. Investors With Losses Exceeding $100K to Secure Counsel Before Important February 8 Deadline in Securities Class Action – RVNC
January 22, 2022 11:10 ET | The Rosen Law Firm PA
NEW YORK, Jan. 22, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between...
GPM Logo.jpg
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC)
January 21, 2022 11:00 ET | Glancy Prongay & Murray LLP
LOS ANGELES, Jan. 21, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 8, 2022 deadline to file a lead plaintiff motion in the class action...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 18, 2022 23:45 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 18, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
DEADLINE ALERT for BLI, PSFE, RVNC, RAAS: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
January 14, 2022 13:30 ET | Law Offices of Howard G. Smith
BENSALEM, Pa., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
GPM Logo.jpg
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Revance Therapeutics, Inc. (RVNC)
January 12, 2022 13:00 ET | Glancy Prongay & Murray LLP
LOS ANGELES, Jan. 12, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 8, 2022 deadline to file a lead plaintiff motion in the class action...
Close Up Logo HD Blue.jpg
DEADLINE ALERT for PSFE, BFT, RVNC, RAAS, and ORGO: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
January 11, 2022 11:45 ET | The Law Offices of Frank R. Cruz
LOS ANGELES, Jan. 11, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following...
July 30, 2021 - ROSEN LOGO.jpg
ROSEN, A LONGSTANDING LAW FIRM, Encourages Revance Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RVNC
January 08, 2022 10:45 ET | The Rosen Law Firm PA
NEW YORK, Jan. 08, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Revance Therapeutics, Inc. (NASDAQ: RVNC) between November...